{
 "edition": "20261105-18",
 "language": "zh-Hans",
 "period_start": "2026-11-05T18:00:00+09:00",
 "period_end": "2026-11-05T21:00:00+09:00",
 "page": 4,
 "pages": 4,
 "received_in_period": 315,
 "listed_in_period": 315,
 "description": "这里一次整合 2 个国家／地区的新闻与公告：台湾 4 个来源 184 条、日本 1 个来源 131 条。每 180 分钟一期，这期入库的所有来源、每一条都列出，附原文网址。",
 "countries": [
  {
   "code": "TW",
   "name": "台湾",
   "items": 184,
   "sources": 4
  },
  {
   "code": "JP",
   "name": "日本",
   "items": 131,
   "sources": 1
  }
 ],
 "number_of_items": 15,
 "items": [
  {
   "id": 3749214,
   "anchor": "n3749214",
   "permalink": "https://ainews.idaeo.ai/180m/20261105-18/index-zh-Hans-p4.html#n3749214",
   "title": "〈港股盘后〉科网与汽车股全线爆发 恒指强涨约900点 科指飙逾5%",
   "title_state": "opencc",
   "summary": "港股周四（5日）强势反弹，恒指涨近900点，科指飙逾5%。科网股如阿里、腾讯、小米大涨，汽车股亦集体走强，惟港股通净流出213亿港元。",
   "summary_state": "opencc",
   "facts": [
    {
     "text": "恒生指數收盘大涨3.67%或近900点，收报24796.98点。",
     "state": "opencc",
     "quote": "恒生指數收盤大漲 3.67%或 近900點，收報 24796.98點"
    },
    {
     "text": "恒生科技指數大涨5.55%，收报4154.29点。",
     "state": "opencc",
     "quote": "恒生科技指數大漲 5.55%，收報 4154.29點"
    },
    {
     "text": "港股通（南向）录得净流出213.26亿港元。",
     "state": "opencc",
     "quote": "今日港股通（南向）錄得淨流出 213.26億港元"
    },
    {
     "text": "阿里巴巴-W大涨8.45%，受惠于苹果国行AI正式落地且Siri深度集成千问模型。",
     "state": "opencc",
     "quote": "阿里巴巴-W 大漲 8.45%，主要受惠於蘋果國行AI正式落地且Siri深度整合千問模型"
    },
    {
     "text": "騰訊控股因混元最新模型Hy4上线，股价大涨7.17%，全日成交额达241.69亿港元。",
     "state": "opencc",
     "quote": "騰訊控股因混元最新模型Hy4上線，股價大漲 7.17%，全日成交額高居港股榜首，達 241.69億港元"
    },
    {
     "text": "理想汽車-W大涨8.94%，蔚來-SW上涨6.95%。",
     "state": "opencc",
     "quote": "理想汽車-W 大漲 8.94%，蔚來-SW 上漲 6.95%"
    },
    {
     "text": "布伦特原油单日暴跌跌超10%，拖累中國石油股份回落4.16%。",
     "state": "opencc",
     "quote": "國際原油單日暴跌（布倫特原油跌超10%）拖累石油股走弱，中國石油股份回落 4.16%"
    }
   ],
   "companies": [
    "恒生指數",
    "恒生科技指數",
    "國企指數",
    "網易",
    "小米集團",
    "阿里巴巴-W",
    "騰訊控股",
    "京東集團",
    "Ceconomy",
    "美團",
    "百度集團",
    "快手",
    "金蝶國際",
    "金山雲",
    "理想汽車-W",
    "蔚來-SW",
    "吉利汽車",
    "零跑汽車",
    "小鵬集團",
    "贛鋒鋰業",
    "寧德時代",
    "中國石油股份"
   ],
   "published_at": "2026-11-05T17:42:05+09:00",
   "source_type": "cnyes",
   "source_name": "鉅亨網",
   "country": "TW",
   "country_name": "台湾",
   "source_language": "zh-TW",
   "url": "https://news.cnyes.com/news/id/6648105",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3749215,
   "anchor": "n3749215",
   "permalink": "https://ainews.idaeo.ai/180m/20261105-18/index-zh-Hans-p4.html#n3749215",
   "title": "〈陆股盘后〉沪指、创指买盘拉升 三大指数走高",
   "title_state": "opencc",
   "summary": "中国A股三大指数周四（5日）开低后翻红走高，沪指、深成指、创指分别收涨0.1%、1.19%、0.87%，成交额增至2.1179兆元。華泰證券与國聯民生分析指出，券商类股估值处低档具配置价值，科技类股则需关注AI算力及应用现金流品质。",
   "summary_state": "opencc",
   "facts": [
    {
     "text": "上证综指周四收盘涨0.1%，报3,689.91点",
     "state": "opencc",
     "quote": "上證綜指周四收盤漲0.1%，報3,689.91點"
    },
    {
     "text": "两市成交额为人民币2.1179兆元，较前一交易日增加802亿元",
     "state": "opencc",
     "quote": "兩市成交額為人民幣2.1179兆元，較前一交易日增加802億元"
    },
    {
     "text": "两市及北交所共4,868家上涨，623家下跌",
     "state": "opencc",
     "quote": "兩市及北交所共4,868家上漲，623家下跌，平盤84家"
    },
    {
     "text": "華泰證券建议投资人把握券商类股战略配置机会",
     "state": "opencc",
     "quote": "展望2027年，建議投資人把握類股戰略配置機會"
    },
    {
     "text": "國聯民生指出AI算力与商业化落地型应用是科技类股内核变量",
     "state": "opencc",
     "quote": "AI算力、商業化落地型應用的訂單持續性與現金流品質，可能會成為決定類股上行空間的核心變量"
    }
   ],
   "companies": [
    "Wind",
    "華泰證券",
    "國聯民生"
   ],
   "published_at": "2026-11-05T17:30:03+09:00",
   "source_type": "cnyes",
   "source_name": "鉅亨網",
   "country": "TW",
   "country_name": "台湾",
   "source_language": "zh-TW",
   "url": "https://news.cnyes.com/news/id/6647108",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3749216,
   "anchor": "n3749216",
   "permalink": "https://ainews.idaeo.ai/180m/20261105-18/index-zh-Hans-p4.html#n3749216",
   "title": "美期中选举引发AI监管疑虑 科技股惨跌拖累日经下跌1.66%",
   "title_state": "opencc",
   "summary": "日本股市周四因美国期中选举引发AI监管疑虑，科技股遭抛售导致日经指数下跌1.66%创近3个月新低；相对地东证指数在传统产业护盘下反弹收高1.2%，两大指数走势严重脱钩。",
   "summary_state": "opencc",
   "facts": [
    {
     "text": "日经指数收盘下跌1.66%或1,030.63点，收在61,158.00点，创下近3个月新低。",
     "state": "opencc",
     "quote": "代表科技權重較高的日經指數在 AI 及半導體族群重挫拖累下，收盤下跌 1.66%或 1,030.63 點，收在 61,158.00 點，創下近 3 個月新低。"
    },
    {
     "text": "东证指数(TOPIX)反弹收高1.2%，与日经指数涨跌幅差距达2.94个百分点。",
     "state": "opencc",
     "quote": "涵蓋廣泛產業的東證指數(TOPIX)在傳統產業護盤下反彈收高 1.2%。兩大指數走勢嚴重脫鉤，漲跌幅差距達 2.94 個百分點，創下 2000 年 4 月以來最大紀錄。"
    },
    {
     "text": "日元兑美元回升至157.90附近。",
     "state": "opencc",
     "quote": "匯市方面，隨美國公債殖利率下滑，日元兌美元回升至 157.90 附近。"
    }
   ],
   "companies": [
    "愛德萬測試",
    "東京威力科創",
    "古河電工",
    "村田製作所",
    "豐田汽車",
    "迅銷",
    "帝人公司",
    "野村證券",
    "東洋證券"
   ],
   "published_at": "2026-11-05T17:20:07+09:00",
   "source_type": "cnyes",
   "source_name": "鉅亨網",
   "country": "TW",
   "country_name": "台湾",
   "source_language": "zh-TW",
   "url": "https://news.cnyes.com/news/id/6647980",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3749217,
   "anchor": "n3749217",
   "permalink": "https://ainews.idaeo.ai/180m/20261105-18/index-zh-Hans-p4.html#n3749217",
   "title": "历史新高！今年Q3全球DRAM营收飙369% 三星市占38%稳居首 SK海力士拉开与美光差距",
   "title_state": "opencc",
   "summary": "今年Q3全球DRAM营收创新高飙升369%，三星以38%市占居首，SK海力士29%紧追，美光21%排名第三。AI需求使内存转为稀缺资源，供应商业绩有望持续刷新。",
   "summary_state": "opencc",
   "facts": [
    {
     "text": "今年第三季全球DRAM市场营收暴涨369%，创下历史新高。",
     "state": "opencc",
     "quote": "今年第三季全球DRAM市場營收暴漲369%，創下歷史新高"
    },
    {
     "text": "三星電子以38%的营收市占率维持全球第一。",
     "state": "opencc",
     "quote": "按營收市佔率計算，南韓三星電子以38%維持第一"
    },
    {
     "text": "SK海力士市占率达29%，拉大与美光科技的差距。",
     "state": "opencc",
     "quote": "SK海力士市佔率達29%，高過第二季26%有3個百分點，拉大與第三名美光科技(21%)的差距"
    },
    {
     "text": "中国長鑫科技第四名市占率从10%微降至9%。",
     "state": "opencc",
     "quote": "第四名中國長鑫科技市佔率則從10%微降至9%"
    },
    {
     "text": "Counterpoint Research预判三星電子有望在明年超越SK海力士拿下HBM市场第一。",
     "state": "opencc",
     "quote": "Counterpoint Research預判三星電子有望在明年超越SK海力士，拿下市場第一"
    }
   ],
   "companies": [
    "三星電子",
    "SK海力士",
    "美光科技",
    "長鑫科技",
    "Counterpoint Research"
   ],
   "published_at": "2026-11-05T17:20:04+09:00",
   "source_type": "cnyes",
   "source_name": "鉅亨網",
   "country": "TW",
   "country_name": "台湾",
   "source_language": "zh-TW",
   "url": "https://news.cnyes.com/news/id/6647979",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3749218,
   "anchor": "n3749218",
   "permalink": "https://ainews.idaeo.ai/180m/20261105-18/index-zh-Hans-p4.html#n3749218",
   "title": "中鋼12月盘价小涨 稳定供应链购料成本扩大接单",
   "title_state": "opencc",
   "summary": "中鋼(2002-TW)宣布12月盘价每公吨调涨300元，以因应国际钢价上涨、外销接单升温及汇率因素，目的在于稳定供应链成本并扩大接单。",
   "summary_state": "opencc",
   "facts": [
    {
     "text": "中鋼12月盘价决议月盘产品每公吨小幅调涨300元。",
     "state": "opencc",
     "quote": "決議月盤產品每公噸小幅調漲300元"
    },
    {
     "text": "美国热轧流通行情突破每公吨1,450美元，创近四年半新高。",
     "state": "opencc",
     "quote": "美國現貨供應偏緊，熱軋流通行情突破每公噸1,450美元，創近四年半新高"
    },
    {
     "text": "铁矿砂价格于每公吨90美元附近盘整。",
     "state": "opencc",
     "quote": "鐵礦砂與冶金煤價格分別於每公噸90美元及265美元附近盤整"
    },
    {
     "text": "中国大陆前三季粗钢产量年减2.9%。",
     "state": "opencc",
     "quote": "中國大陸前三季粗鋼產量年減2.9%"
    },
    {
     "text": "日本東京製鐵11月盘价每公吨调涨3,000日圆。",
     "state": "opencc",
     "quote": "日本東京製鐵11月盤價每公噸調漲3,000日圓（約19美元）"
    }
   ],
   "companies": [
    "中鋼",
    "中鋼(2002-TW)",
    "日本東京製鐵",
    "越南和發鋼廠"
   ],
   "published_at": "2026-11-05T17:10:17+09:00",
   "source_type": "cnyes",
   "source_name": "鉅亨網",
   "country": "TW",
   "country_name": "台湾",
   "source_language": "zh-TW",
   "url": "https://news.cnyes.com/news/id/6647973",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3749219,
   "anchor": "n3749219",
   "permalink": "https://ainews.idaeo.ai/180m/20261105-18/index-zh-Hans-p4.html#n3749219",
   "title": "民主党大胜美股先崩后拉回、金银齐扬 市场押注「谁也动不了谁」",
   "title_state": "opencc",
   "summary": "美国期中选举民主党大胜夺回国会两院，引发全球市场先跌后涨的反转行情。市场重新定价分权政府带来的政策僵局，预期其将限制财政扩张，进而利好美债与金银，科技股则受监管担忧短期承压。",
   "summary_state": "opencc",
   "facts": [
    {
     "text": "民主党在美国期中选举中夺回国会参众两院，并在德州、南卡罗来纳州等共和党传统优势地区胜出。",
     "state": "opencc",
     "quote": "民主黨不僅拿下眾參兩院，更在德州、南卡羅來納州、堪薩斯州及愛荷華州等共和黨傳統優勢地區勝出"
    },
    {
     "text": "选后那斯达克100指数期货一度跌逾2%，日经225指数一度跌逾4%，VIX恐慌指数期货突破20。",
     "state": "opencc",
     "quote": "那斯達克100指數期貨一度跌逾2%...VIX恐慌指數期貨突破20。亞洲市場同步承壓，日經225指數一度跌逾4%"
    },
    {
     "text": "黄金价格上涨逾2%，重返每盎司4000美元关卡，白银同步上扬。",
     "state": "opencc",
     "quote": "金價上漲逾2%，重返每盎司4000美元關卡，白銀同步上揚"
    },
    {
     "text": "5年期美债殖利率一度下跌9个基点至4.68%，10年期下跌7个基点至4.89%。",
     "state": "opencc",
     "quote": "5年期殖利率一度下跌9個基點至4.68%，10年期下跌7個基點至4.89%"
    },
    {
     "text": "彭博美元现货指数下跌0.4%，日元兑美元升值0.5%，瑞郎上涨0.7%。",
     "state": "opencc",
     "quote": "彭博美元現貨指數下跌0.4%，日元兌美元升值0.5%，瑞郎上漲0.7%"
    }
   ],
   "companies": [
    "高盛",
    "Stifel",
    "景順",
    "摩根資產管理",
    "惠靈頓",
    "野村",
    "瑞穗銀行",
    "盛寶",
    "Monex Group",
    "道富環球投資管理",
    "Edward Jones"
   ],
   "published_at": "2026-11-05T17:10:05+09:00",
   "source_type": "cnyes",
   "source_name": "鉅亨網",
   "country": "TW",
   "country_name": "台湾",
   "source_language": "zh-TW",
   "url": "https://news.cnyes.com/news/id/6647627",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3749647,
   "anchor": "n3749647",
   "permalink": "https://ainews.idaeo.ai/180m/20261105-18/index-zh-Hans-p4.html#n3749647",
   "title": "2026-11-05法人动态：(买超)晟德404张、美時381张、保瑞334张；(卖超)松瑞藥233张、浩鼎221张、漢達217张-环球生技月刊",
   "title_state": "opencc",
   "summary": "2026年11月5日法人动态，晟德、美時、保瑞为买超前三名；松瑞藥、浩鼎、漢達为卖超前三名。",
   "summary_state": "opencc",
   "facts": [],
   "companies": [
    "晟德",
    "美時",
    "保瑞",
    "松瑞藥",
    "浩鼎",
    "漢達",
    "東洋",
    "高端疫苗",
    "合一",
    "台耀",
    "神隆",
    "科妍",
    "葡萄王",
    "大江"
   ],
   "published_at": "2026-11-05T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "台湾",
   "source_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=91115&kind=20",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3749646,
   "anchor": "n3749646",
   "permalink": "https://ainews.idaeo.ai/180m/20261105-18/index-zh-Hans-p4.html#n3749646",
   "title": "2026-11-05生技股：(涨)科妍9.97%、康霈*9.9%、美時5.66%；(跌)漢達9.87%、泰合8.29%、台新藥7.95%-环球生技月刊",
   "title_state": "opencc",
   "summary": "2026年11月5日生技股行情，科妍涨9.97%居冠，漢達跌9.87%领跌。",
   "summary_state": "opencc",
   "facts": [],
   "companies": [
    "科妍",
    "康霈*",
    "美時",
    "保瑞",
    "台聯電",
    "視陽",
    "海昌生技",
    "醫影",
    "佰研",
    "馬光-KY",
    "漢達",
    "泰合",
    "台新藥",
    "睿生光電",
    "霈方",
    "泰宗",
    "上亞科技",
    "強生*"
   ],
   "published_at": "2026-11-05T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "台湾",
   "source_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=91116&kind=20",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3749645,
   "anchor": "n3749645",
   "permalink": "https://ainews.idaeo.ai/180m/20261105-18/index-zh-Hans-p4.html#n3749645",
   "title": "11/05《生技股动态》-环球生技月刊",
   "title_state": "opencc",
   "summary": "11/05生技股动态涵盖安基生技、國璽幹細胞等公司之增资与合并案，康霈获中国NMPA核准一期临床试验，并列出当日涨跌及法人买卖超情形。",
   "summary_state": "opencc",
   "facts": [
    {
     "text": "现增1400万股",
     "state": "opencc",
     "quote": "現增1400萬股"
    },
    {
     "text": "每股60元",
     "state": "opencc",
     "quote": "每股60元"
    },
    {
     "text": "基准日12/6",
     "state": "opencc",
     "quote": "基準日12/6"
    },
    {
     "text": "暂定合并基准日115/12/31",
     "state": "opencc",
     "quote": "暫定合併基準日115/12/31"
    },
    {
     "text": "基准日暂定116/1/1",
     "state": "opencc",
     "quote": "基準日暫定116/1/1"
    },
    {
     "text": "科妍9.97%",
     "state": "opencc",
     "quote": "科妍9.97%"
    },
    {
     "text": "康霈*9.9%",
     "state": "opencc",
     "quote": "康霈*9.9%"
    },
    {
     "text": "美時5.66%",
     "state": "opencc",
     "quote": "美時5.66%"
    },
    {
     "text": "漢達9.87%",
     "state": "opencc",
     "quote": "漢達9.87%"
    },
    {
     "text": "泰合8.29%",
     "state": "opencc",
     "quote": "泰合8.29%"
    },
    {
     "text": "台新藥7.95%",
     "state": "opencc",
     "quote": "台新藥7.95%"
    },
    {
     "text": "晟德404张",
     "state": "opencc",
     "quote": "晟德404張"
    },
    {
     "text": "美時381张",
     "state": "opencc",
     "quote": "美時381張"
    },
    {
     "text": "保瑞334张",
     "state": "opencc",
     "quote": "保瑞334張"
    },
    {
     "text": "松瑞藥233张",
     "state": "opencc",
     "quote": "松瑞藥233張"
    },
    {
     "text": "浩鼎221张",
     "state": "opencc",
     "quote": "浩鼎221張"
    },
    {
     "text": "漢達217张",
     "state": "opencc",
     "quote": "漢達217張"
    }
   ],
   "companies": [
    "安基生技",
    "國璽幹細胞",
    "啟安",
    "敏成健康",
    "躍獅健康",
    "精湛光學",
    "康霈",
    "科妍",
    "美時",
    "漢達",
    "泰合",
    "台新藥",
    "晟德",
    "保瑞",
    "松瑞藥",
    "浩鼎"
   ],
   "published_at": "2026-11-05T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "台湾",
   "source_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=91117&kind=20",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3749644,
   "anchor": "n3749644",
   "permalink": "https://ainews.idaeo.ai/180m/20261105-18/index-zh-Hans-p4.html#n3749644",
   "title": "精湛光學(2070)115年前三季合并获利1.06亿元，每股税后2.62元-環球生技月刊",
   "title_state": "opencc",
   "summary": "精湛光學(2070)公告115年前三季合并财务报告，累计营业收入6.01亿元，税前净利1.24亿元，归属于母公司业主净利1.06亿元，基本每股盈余2.62元。",
   "summary_state": "opencc",
   "facts": [
    {
     "text": "601,445",
     "state": "opencc",
     "quote": "601,445"
    },
    {
     "text": "105,611",
     "state": "opencc",
     "quote": "105,611"
    },
    {
     "text": "124,051",
     "state": "opencc",
     "quote": "124,051"
    }
   ],
   "companies": [
    "精湛光學",
    "環球生技月刊"
   ],
   "published_at": "2026-11-05T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "台湾",
   "source_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=91126&kind=21",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3749643,
   "anchor": "n3749643",
   "permalink": "https://ainews.idaeo.ai/180m/20261105-18/index-zh-Hans-p4.html#n3749643",
   "title": "国玺干细胞(6704)董事会决议与子公司启安简易合并，暂定合并基准日115/12/31-环球生技月刊",
   "title_state": "opencc",
   "summary": "國璽幹細胞應用技術股份有限公司（6704）董事会决议与100%持股子公司啟安國際生醫投資股份有限公司进行简易合并，暂定合并基准日为115年12月31日，旨在精简管理费用及成本。",
   "summary_state": "opencc",
   "facts": [
    {
     "text": "直接持股100%",
     "state": "opencc",
     "quote": "直接持股100%"
    },
    {
     "text": "事实发生日 115/11/05",
     "state": "opencc",
     "quote": "事實發生日 115/11/05"
    }
   ],
   "companies": [
    "國璽幹細胞應用技術股份有限公司",
    "國璽公司",
    "啟安國際生醫投資股份有限公司",
    "啟安公司"
   ],
   "published_at": "2026-11-05T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "台湾",
   "source_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=91127&kind=21",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3749642,
   "anchor": "n3749642",
   "permalink": "https://ainews.idaeo.ai/180m/20261105-18/index-zh-Hans-p4.html#n3749642",
   "title": "国玺干细胞(6704)董事会决议与子公司启安简易合并，债权人异议期11/6~12/30-环球生技月刊",
   "title_state": "opencc",
   "summary": "国玺干细胞(6704)子公司啟安國際生醫投資股份有限公司经董事会决议与母公司进行简易合并，暂订合并基准日为115年12月31日，债权人异议期为115年11月6日至12月30日。",
   "summary_state": "opencc",
   "facts": [
    {
     "text": "100%持有",
     "state": "opencc",
     "quote": "100%持有"
    },
    {
     "text": "民国(下同)115年11月05日",
     "state": "opencc",
     "quote": "民國(下同)115年11月05日"
    },
    {
     "text": "暂订合并基准日为115年12月31日",
     "state": "opencc",
     "quote": "暫訂合併基準日為115年12月31日"
    },
    {
     "text": "115年11月06日至115年12月30日期间内",
     "state": "opencc",
     "quote": "115年11月06日至115年12月30日期間內"
    }
   ],
   "companies": [
    "國璽幹細胞應用技術股份有限公司",
    "啟安國際生醫投資股份有限公司"
   ],
   "published_at": "2026-11-05T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "台湾",
   "source_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=91128&kind=21",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3749641,
   "anchor": "n3749641",
   "permalink": "https://ainews.idaeo.ai/180m/20261105-18/index-zh-Hans-p4.html#n3749641",
   "title": "國璽幹細胞(6704)：子公司启安与母公司简易合并，暂定合并基准日115/12/31-环球生技月刊",
   "title_state": "opencc",
   "summary": "國璽幹細胞(6704)公告子公司啟安國際生醫投資股份有限公司与母公司进行简易合并，暂定合并基准日为115/12/31，旨在精简管理费用及成本。",
   "summary_state": "opencc",
   "facts": [
    {
     "text": "直接持股100%",
     "state": "opencc",
     "quote": "直接持股100%"
    },
    {
     "text": "事实发生日 115/11/05",
     "state": "opencc",
     "quote": "事實發生日 115/11/05"
    }
   ],
   "companies": [
    "國璽幹細胞應用技術股份有限公司",
    "國璽公司",
    "啟安國際生醫投資股份有限公司",
    "啟安公司",
    "國璽幹細胞"
   ],
   "published_at": "2026-11-05T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "台湾",
   "source_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=91129&kind=21",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3749640,
   "anchor": "n3749640",
   "permalink": "https://ainews.idaeo.ai/180m/20261105-18/index-zh-Hans-p4.html#n3749640",
   "title": "安基生技(7754)现增1400万股案，每股60元，基准日12/6-环球生技月刊",
   "title_state": "opencc",
   "summary": "安基生技(7754)公告现金增资1,400万股，每股发行价格60元，认股基准日订为115年12月6日，资金用途为充实营运资金。",
   "summary_state": "opencc",
   "facts": [
    {
     "text": "14,000,000股",
     "state": "opencc",
     "quote": "14,000,000股"
    },
    {
     "text": "每股新台币60元整",
     "state": "opencc",
     "quote": "每股新台幣60元整"
    },
    {
     "text": "140,000,000元整",
     "state": "opencc",
     "quote": "140,000,000元整"
    },
    {
     "text": "1,400,000股",
     "state": "opencc",
     "quote": "1,400,000股"
    },
    {
     "text": "12,600,000股",
     "state": "opencc",
     "quote": "12,600,000股"
    }
   ],
   "companies": [
    "安基生技"
   ],
   "published_at": "2026-11-05T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "台湾",
   "source_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=91130&kind=21",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3749630,
   "anchor": "n3749630",
   "permalink": "https://ainews.idaeo.ai/180m/20261105-18/index-zh-Hans-p4.html#n3749630",
   "title": "安基生技(7754)现增1400万股案，每股60元，基准日12/6-环球生技月刊",
   "title_state": "opencc",
   "summary": "安基生技(7754)公告现金增资案，发行1,400万股，每股认购价60元，基准日订为115年12月6日，资金用途为充实营运资金。",
   "summary_state": "opencc",
   "facts": [
    {
     "text": "14,000,000股",
     "state": "opencc",
     "quote": "14,000,000股"
    },
    {
     "text": "每股新台币60元整",
     "state": "opencc",
     "quote": "每股新台幣60元整"
    },
    {
     "text": "140,000,000元整",
     "state": "opencc",
     "quote": "140,000,000元整"
    },
    {
     "text": "1,400,000股",
     "state": "opencc",
     "quote": "1,400,000股"
    },
    {
     "text": "12,600,000股",
     "state": "opencc",
     "quote": "12,600,000股"
    }
   ],
   "companies": [
    "安基生技"
   ],
   "published_at": "2026-11-05T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "台湾",
   "source_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=91130&range=news",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  }
 ]
}